Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1368 ARTÍCULOS , VIENDO DEL 256 AL 270

The Roles of Apolipoprotein E, Lipids, and Glucose in the Pathogenesis of Alzheimer's Disease

Shinohara M, Sato N.

Adv Exp Med Biol. 2019;1128:85-101. doi: 10.1007/978-981-13-3540-2_5.

Diabetes-Related Dementia

Hanyu H.

Adv Exp Med Biol. 2019;1128:147-160. doi: 10.1007/978-981-13-3540-2_8.

Tortuous Paths of Insulin Signaling and Mitochondria in Alzheimer's Disease

Carvalho C, Cardoso SM, Correia SC, Moreira PI.

Adv Exp Med Biol. 2019;1128:161-183. doi: 10.1007/978-981-13-3540-2_9.

Mammalian Target of Rapamycin at the Crossroad Between Alzheimer's Disease and Diabetes

Liang H, Nie J, Van Skike CE, Valentine JM, Orr ME.

Adv Exp Med Biol. 2019;1128:185-225. doi: 10.1007/978-981-13-3540-2_10.

Therapeutic Strategies for Alzheimer's Disease in the View of Diabetes Mellitus

Ohyagi Y, Miyoshi K, Nakamura N.

Adv Exp Med Biol. 2019;1128:227-248. doi: 10.1007/978-981-13-3540-2_11.

Editorial: Failure After Failure. What Next in AD Drug Development?

Aisen PS.

J Prev Alzheimers Dis. 2019;6(3):150. doi: 10.14283/jpad.2019.23.

Silymarin's Inhibition and Treatment Effects for Alzheimer's Disease

Guo H, Cao H, Cui X, Zheng W, Wang S, Yu J, Chen Z.

Molecules. 2019 May 6;24(9):1748. doi: 10.3390/molecules24091748.

Effect of CYP2D6 and CYP3A4 Genotypes on the Efficacy of Cholinesterase Inhibitors in Southern Chinese Patients With Alzheimer's Disease

Ma SL, Tang NLS, Wat KHY, Tang JHY, Lau KH, Law CB, Chiu J, Tam CCW, Poon TK, Lin KL, Kng CPL, Kong HL, Chan TY, Chan WC, Lam LCW.

Am J Alzheimers Dis Other Demen. 2019 Aug;34(5):302-307. doi: 10.1177/1533317519848237. Epub 2019 May 7.

AGE-RAGE stress: a changing landscape in pathology and treatment of Alzheimer's disease

Prasad K.

Mol Cell Biochem. 2019 Sep;459(1-2):95-112. doi: 10.1007/s11010-019-03553-4. Epub 2019 May 11.

Natural Compounds for Alzheimer's Disease Therapy: A Systematic Review of Preclinical and Clinical Studies

Andrade S, Ramalho MJ, Loureiro JA, Pereira MDC.

Int J Mol Sci. 2019 May 10;20(9):2313. doi: 10.3390/ijms20092313.

Crucial players in Alzheimer's disease and diabetes mellitus: Friends or foes?

Kubis-Kubiak AM, Rorbach-Dolata A, Piwowar A.

Mech Ageing Dev. 2019 Jul;181:7-21. doi: 10.1016/j.mad.2019.03.008. Epub 2019 May 11.

Development and validation of Alzheimer's Disease Animal Model for the Purpose of Regenerative Medicine

Goodarzi P, Payab M, Alavi-Moghadam S, Larijani B, Rahim F, Bana N, Sarvari M, Adibi H, Foroughi Heravani N, Hadavandkhani M, Arjmand B.

Cell Tissue Bank. 2019 Jun;20(2):141-151. doi: 10.1007/s10561-019-09773-8. Epub 2019 May 13.

Elucidating Tau function and dysfunction in the era of cryo-EM

Lippens G, Gigant B.

J Biol Chem. 2019 Jun 14;294(24):9316-9325. doi: 10.1074/jbc.REV119.008031. Epub 2019 May 14.

Microbiota Alterations in Alzheimer's Disease: Involvement of the Kynurenine Pathway and Inflammation

Garcez ML, Jacobs KR, Guillemin GJ.

Neurotox Res. 2019 Aug;36(2):424-436. doi: 10.1007/s12640-019-00057-3. Epub 2019 May 14.

NQO1: A target for the treatment of cancer and neurological diseases, and a model to understand loss of function disease mechanisms

Beaver SK, Mesa-Torres N, Pey AL, Timson DJ.

Biochim Biophys Acta Proteins Proteom. 2019 Jul-Aug;1867(7-8):663-676. doi: 10.1016/j.bbapap.2019.05.002. Epub 2019 May 12.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias